Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs

Vaccine
Amy L VincentKelly M Lager

Abstract

The gene constellation of the 2009 pandemic A/H1N1 virus is a unique combination from swine influenza A viruses (SIV) of North American and Eurasian lineages, but prior to April 2009 had never before been identified in swine or other species. Although its hemagglutinin gene is related to North American H1 SIV, it is unknown if vaccines currently used in U.S. swine would cross-protect against infection with the pandemic A/H1N1. The objective of this study was to evaluate the efficacy of inactivated vaccines prepared with North American swine influenza viruses as well as an experimental homologous A/H1N1 vaccine to prevent infection and disease from 2009 pandemic A/H1N1. All vaccines tested provided partial protection ranging from reduction of pneumonia lesions to significant reduction in virus replication in the lung and nose. The multivalent vaccines demonstrated partial protection; however, none was able to prevent all nasal shedding or clinical disease. An experimental homologous 2009 A/H1N1 monovalent vaccine provided optimal protection with no virus detected from nose or lung at any time point in addition to amelioration of clinical disease. Based on cross-protection demonstrated with the vaccines evaluated in this study, t...Continue Reading

References

Apr 20, 2006·Veterinary Immunology and Immunopathology·Pravina KitikoonEileen L Thacker
Mar 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kendall P MyersGregory C Gray
Jun 6, 2008·Journal of Clinical Microbiology·Erin L StraitEileen L Thacker
May 29, 2009·The New England Journal of Medicine·Vladimir TrifonovRaul Rabadan
Jun 16, 2009·The Veterinary Record·Sharon M BrookesGiovanni Cattoli

❮ Previous
Next ❯

Citations

Jan 1, 2014·Research in Veterinary Science·Guohua ChenXuepeng Cai
Feb 26, 2013·Archives of Virology·Nobuhiro TakemaeTakehiko Saito
Dec 22, 2011·Veterinary Research·Anna RomagosaMontserrat Torremorell
May 14, 2010·Animal Health Research Reviews·Wenjun Ma, Jürgen A Richt
Dec 21, 2012·Animal Health Research Reviews·Qi ChenD L Hank Harris
Jun 29, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen K WongCarrie Reed
Jul 26, 2012·Transboundary and Emerging Diseases·C A CorzoM Torremorell
Jan 25, 2017·Vaccine·Santosh DhakalGourapura J Renukaradhya
Sep 8, 2015·Vaccines·Matthew R SandbulteJames A Roth
Oct 21, 2017·Influenza and Other Respiratory Viruses·Andres H GutiérrezAnne S De Groot
Jun 24, 2011·Journal of Virology·Charles K NfonJohn Pasick
Sep 16, 2011·Clinical and Vaccine Immunology : CVI·J Patrick GorresSrinivas S Rao
Jan 1, 2014·Emerging Microbes & Infections·Andrew S BowmanRichard D Slemons
Nov 17, 2020·Frontiers in Veterinary Science·José Carlos Mancera GraciaMonica Balasch
Mar 1, 2017·Veterinary Immunology and Immunopathology·Zahra F OlsonCrystal L Loving

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.